CB2 Insights - (CSE: CBII) (OTC: Coming Soon) - Investor Dashboard
|Employees:||182 as of 3/21/19|
CB2 Insights – Cannabis Platforms and Business Lines
Building a 360˚ View of Patient’s Treatment Progress
with Data-driven Software & Services For The Cannabis Industry
Traditional Healthcare Protocol for Cannabis
In 2014, healthcare entrepreneurs Prad Sekar and Kash Qureshi were asked to help educate physicians across Canada on how best to prescribe medical cannabis to a rapidly growing patient population. At a time where social stigma, limited medical research and the overall complexity of prescribing cannabis as a medicine all converged, Sekar and Qureshi knew that they would have to bring traditional healthcare protocols to the cannabis industry before the cannabis industry could properly integrate with healthcare.
The Industry’s First CDS Tool
After developing the industry’s first Clinical Decision Support tool to help guide physicians when prescribing medical cannabis, the company gained traction in international markets which eventually led to the acquisition of a large cannabis evaluation center group in the US which has since grown to become the largest multi-state cannabis evaluation and education group in the country.
The Largest Cannabis Patient Registry
Today, CB2 Insights is recognized as having the largest cannabis patient registry across 12 states in the US as well as growing international reach and has deployed the industry’s most comprehensive data collection tool built to drive Real-World Evidence specific to medical cannabis treatment.
Unparalleled Cannabis Data
With millions of clinically-validated data points collected through our own clinic network, we are now able to objectively measure cannabis trends and efficacy in a way that no other industry player can.
New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. CB2 Insights is a client of NCV Media, LLC. Read our full disclaimer.